Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2026-2032
The global Inactivated Polio Vaccine market size is expected to reach $ 1640 million by 2032, rising at a market growth of 4.2% CAGR during the forecast period (2026-2032).
Inactivated Polio Vaccine (IPV) is a preventive biological product produced from poliovirus types I, II, and III through cell culture, virus harvest, purification, inactivation, formulation, and aseptic filling. Administered by injection, it induces active immunity against polioviruses and helps prevent poliomyelitis infection and the risk of acute flaccid paralysis. Based on production strain sources, IPV can include conventional wild-strain IPV and Sabin-strain IPV; based on product form, it can be supplied as a standalone vaccine or as an IPV-containing combination vaccine. Compared with oral live attenuated polio vaccines, IPV does not involve live virus replication risk and has strategic value in safety enhancement, immunization program upgrading, late-stage polio eradication risk control, and international public health supply. It is a core pediatric vaccine category with both public health importance and high technical barriers.In 2025, global Inactivated Polio Vaccine (IPV) production reached approximately 586.15 million units.The average gross profit margin of this product is 75%.
The market opportunities for Inactivated Polio Vaccine are driven by the critical late stage of global polio eradication, continuous optimization of immunization programs, and rising safety requirements for vaccines. As countries gradually reduce reliance on oral live attenuated polio vaccines, IPV is gaining stronger importance in primary immunization, sequential schedules, and catch-up vaccination strategies. China?s disease control system has clarified the coordination between IPV and OPV in immunization schedules, while national disease control authorities continue to promote IPV catch-up vaccination for targeted populations. This highlights the long-term value of IPV in maintaining polio-free status, preventing importation risks, and strengthening immune barriers. For manufacturers, IPV is not only a traditional immunization program vaccine, but also a platform product connecting public health procurement, domestic substitution, international organization supply, and combination vaccine upgrading, with stable demand, long-term access value, and strategic reserve attributes.
The industry?s challenges are concentrated in high biosafety requirements, complex manufacturing processes, strict quality regulation, and its strong public-goods attribute. IPV production involves virus seed lot management, cell substrate control, virus culture, purification, inactivation validation, antigen quantification, aseptic filling, and batch release. Each step directly affects vaccine safety, immunogenicity, and batch-to-batch consistency. Because polio vaccines are administered to infants and used in national immunization program settings, regulators impose extremely high requirements on registration approval, GMP, cold chain, traceability, adverse event monitoring, and post-marketing safety management. At the same time, IPV pricing is strongly influenced by government procurement, public health budgets, and international organization purchasing rules. Manufacturers must ensure stable supply while controlling production costs and quality risks. Future competition will shift from pure capacity expansion to integrated competition in process platforms, quality systems, and global compliance capability.
Downstream demand is expanding from basic childhood immunization to sequential vaccination, catch-up vaccination, international travel health, emergency response to importation risks, and combination vaccine upgrading. Disease control systems place greater emphasis on stable vaccine supply, batch traceability, cold-chain friendliness, and quality assurance suitable for large-scale vaccination. Vaccination clinics require products with clear dosage forms, standardized operation, stable distribution, and smooth compatibility with immunization schedules. Parents pay increasing attention to vaccine safety, convenience, and brand credibility. As pediatric vaccination evolves toward fewer injections, greater convenience, and premium immunization solutions, standalone IPV will continue to serve as a safety foundation for basic immunization, while also becoming an important antigen module for multivalent vaccine development. Its commercial value will extend from single-product supply to broader pediatric immunization solutions.
This report studies the global Inactivated Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inactivated Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inactivated Polio Vaccine total production and demand, 2021-2032, (K Dose)
Global Inactivated Polio Vaccine total production value, 2021-2032, (USD Million)
Global Inactivated Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Inactivated Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Inactivated Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Inactivated Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Inactivated Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Inactivated Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Serum Institute of India, Bharat Biotech, Bilthoven Biologicals, Bio Farma, Panacea Biotec, Sinovac, Beijing Tiantan Biological, IMBCAMS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Inactivated Polio Vaccine Market, By Region:
1. How big is the global Inactivated Polio Vaccine market?
2. What is the demand of the global Inactivated Polio Vaccine market?
3. What is the year over year growth of the global Inactivated Polio Vaccine market?
4. What is the production and production value of the global Inactivated Polio Vaccine market?
5. Who are the key producers in the global Inactivated Polio Vaccine market?
6. What are the growth factors driving the market demand?
Inactivated Polio Vaccine (IPV) is a preventive biological product produced from poliovirus types I, II, and III through cell culture, virus harvest, purification, inactivation, formulation, and aseptic filling. Administered by injection, it induces active immunity against polioviruses and helps prevent poliomyelitis infection and the risk of acute flaccid paralysis. Based on production strain sources, IPV can include conventional wild-strain IPV and Sabin-strain IPV; based on product form, it can be supplied as a standalone vaccine or as an IPV-containing combination vaccine. Compared with oral live attenuated polio vaccines, IPV does not involve live virus replication risk and has strategic value in safety enhancement, immunization program upgrading, late-stage polio eradication risk control, and international public health supply. It is a core pediatric vaccine category with both public health importance and high technical barriers.In 2025, global Inactivated Polio Vaccine (IPV) production reached approximately 586.15 million units.The average gross profit margin of this product is 75%.
The market opportunities for Inactivated Polio Vaccine are driven by the critical late stage of global polio eradication, continuous optimization of immunization programs, and rising safety requirements for vaccines. As countries gradually reduce reliance on oral live attenuated polio vaccines, IPV is gaining stronger importance in primary immunization, sequential schedules, and catch-up vaccination strategies. China?s disease control system has clarified the coordination between IPV and OPV in immunization schedules, while national disease control authorities continue to promote IPV catch-up vaccination for targeted populations. This highlights the long-term value of IPV in maintaining polio-free status, preventing importation risks, and strengthening immune barriers. For manufacturers, IPV is not only a traditional immunization program vaccine, but also a platform product connecting public health procurement, domestic substitution, international organization supply, and combination vaccine upgrading, with stable demand, long-term access value, and strategic reserve attributes.
The industry?s challenges are concentrated in high biosafety requirements, complex manufacturing processes, strict quality regulation, and its strong public-goods attribute. IPV production involves virus seed lot management, cell substrate control, virus culture, purification, inactivation validation, antigen quantification, aseptic filling, and batch release. Each step directly affects vaccine safety, immunogenicity, and batch-to-batch consistency. Because polio vaccines are administered to infants and used in national immunization program settings, regulators impose extremely high requirements on registration approval, GMP, cold chain, traceability, adverse event monitoring, and post-marketing safety management. At the same time, IPV pricing is strongly influenced by government procurement, public health budgets, and international organization purchasing rules. Manufacturers must ensure stable supply while controlling production costs and quality risks. Future competition will shift from pure capacity expansion to integrated competition in process platforms, quality systems, and global compliance capability.
Downstream demand is expanding from basic childhood immunization to sequential vaccination, catch-up vaccination, international travel health, emergency response to importation risks, and combination vaccine upgrading. Disease control systems place greater emphasis on stable vaccine supply, batch traceability, cold-chain friendliness, and quality assurance suitable for large-scale vaccination. Vaccination clinics require products with clear dosage forms, standardized operation, stable distribution, and smooth compatibility with immunization schedules. Parents pay increasing attention to vaccine safety, convenience, and brand credibility. As pediatric vaccination evolves toward fewer injections, greater convenience, and premium immunization solutions, standalone IPV will continue to serve as a safety foundation for basic immunization, while also becoming an important antigen module for multivalent vaccine development. Its commercial value will extend from single-product supply to broader pediatric immunization solutions.
This report studies the global Inactivated Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inactivated Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inactivated Polio Vaccine total production and demand, 2021-2032, (K Dose)
Global Inactivated Polio Vaccine total production value, 2021-2032, (USD Million)
Global Inactivated Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Inactivated Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Inactivated Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Inactivated Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Inactivated Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Inactivated Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Serum Institute of India, Bharat Biotech, Bilthoven Biologicals, Bio Farma, Panacea Biotec, Sinovac, Beijing Tiantan Biological, IMBCAMS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Inactivated Polio Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Childhood Basic Immunization
- Special Populations
- Monovalent
- Bivalent
- Trivalent
- Multivalent
- Vero Cell
- Human Diploid
- Primary Cell
- Recombinant
- Pediatrics
- Adults
- Sanofi
- GSK
- Serum Institute of India
- Bharat Biotech
- Bilthoven Biologicals
- Bio Farma
- Panacea Biotec
- Sinovac
- Beijing Tiantan Biological
- IMBCAMS
1. How big is the global Inactivated Polio Vaccine market?
2. What is the demand of the global Inactivated Polio Vaccine market?
3. What is the year over year growth of the global Inactivated Polio Vaccine market?
4. What is the production and production value of the global Inactivated Polio Vaccine market?
5. Who are the key producers in the global Inactivated Polio Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Inactivated Polio Vaccine Introduction
1.2 World Inactivated Polio Vaccine Supply & Forecast
1.2.1 World Inactivated Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Inactivated Polio Vaccine Production (2021-2032)
1.2.3 World Inactivated Polio Vaccine Pricing Trends (2021-2032)
1.3 World Inactivated Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Inactivated Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Inactivated Polio Vaccine Production by Region (2021-2032)
1.3.3 World Inactivated Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Inactivated Polio Vaccine Production (2021-2032)
1.3.5 Europe Inactivated Polio Vaccine Production (2021-2032)
1.3.6 China Inactivated Polio Vaccine Production (2021-2032)
1.3.7 Japan Inactivated Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Inactivated Polio Vaccine Demand (2021-2032)
2.2 World Inactivated Polio Vaccine Consumption by Region
2.2.1 World Inactivated Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Inactivated Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Inactivated Polio Vaccine Consumption (2021-2032)
2.4 China Inactivated Polio Vaccine Consumption (2021-2032)
2.5 Europe Inactivated Polio Vaccine Consumption (2021-2032)
2.6 Japan Inactivated Polio Vaccine Consumption (2021-2032)
2.7 South Korea Inactivated Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Inactivated Polio Vaccine Consumption (2021-2032)
2.9 India Inactivated Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Inactivated Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Inactivated Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Inactivated Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Inactivated Polio Vaccine in 2025
3.6 Inactivated Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Inactivated Polio Vaccine Market: Region Footprint
3.6.2 Inactivated Polio Vaccine Market: Company Product Type Footprint
3.6.3 Inactivated Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Inactivated Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Inactivated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Inactivated Polio Vaccine Production Comparison
4.2.1 United States VS China: Inactivated Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Inactivated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Inactivated Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Inactivated Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Inactivated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Inactivated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inactivated Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Inactivated Polio Vaccine Production (2021-2026)
4.5 China Based Inactivated Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inactivated Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Inactivated Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Inactivated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Inactivated Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Childhood Basic Immunization
5.2.2 Special Populations
5.3 Market Segment by Type
5.3.1 World Inactivated Polio Vaccine Production by Type (2021-2032)
5.3.2 World Inactivated Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Inactivated Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VALENCY
6.1 World Inactivated Polio Vaccine Market Size Overview by Valency: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Valency
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.2.4 Multivalent
6.3 Market Segment by Valency
6.3.1 World Inactivated Polio Vaccine Production by Valency (2021-2032)
6.3.2 World Inactivated Polio Vaccine Production Value by Valency (2021-2032)
6.3.3 World Inactivated Polio Vaccine Average Price by Valency (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION CELL
7.1 World Inactivated Polio Vaccine Market Size Overview by Production Cell: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Cell
7.2.1 Vero Cell
7.2.2 Human Diploid
7.2.3 Primary Cell
7.2.4 Recombinant
7.3 Market Segment by Production Cell
7.3.1 World Inactivated Polio Vaccine Production by Production Cell (2021-2032)
7.3.2 World Inactivated Polio Vaccine Production Value by Production Cell (2021-2032)
7.3.3 World Inactivated Polio Vaccine Average Price by Production Cell (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Inactivated Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pediatrics
8.2.2 Adults
8.3 Market Segment by Application
8.3.1 World Inactivated Polio Vaccine Production by Application (2021-2032)
8.3.2 World Inactivated Polio Vaccine Production Value by Application (2021-2032)
8.3.3 World Inactivated Polio Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Inactivated Polio Vaccine Product and Services
9.1.4 Sanofi Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Inactivated Polio Vaccine Product and Services
9.2.4 GSK Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Serum Institute of India
9.3.1 Serum Institute of India Details
9.3.2 Serum Institute of India Major Business
9.3.3 Serum Institute of India Inactivated Polio Vaccine Product and Services
9.3.4 Serum Institute of India Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Serum Institute of India Recent Developments/Updates
9.3.6 Serum Institute of India Competitive Strengths & Weaknesses
9.4 Bharat Biotech
9.4.1 Bharat Biotech Details
9.4.2 Bharat Biotech Major Business
9.4.3 Bharat Biotech Inactivated Polio Vaccine Product and Services
9.4.4 Bharat Biotech Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Bharat Biotech Recent Developments/Updates
9.4.6 Bharat Biotech Competitive Strengths & Weaknesses
9.5 Bilthoven Biologicals
9.5.1 Bilthoven Biologicals Details
9.5.2 Bilthoven Biologicals Major Business
9.5.3 Bilthoven Biologicals Inactivated Polio Vaccine Product and Services
9.5.4 Bilthoven Biologicals Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Bilthoven Biologicals Recent Developments/Updates
9.5.6 Bilthoven Biologicals Competitive Strengths & Weaknesses
9.6 Bio Farma
9.6.1 Bio Farma Details
9.6.2 Bio Farma Major Business
9.6.3 Bio Farma Inactivated Polio Vaccine Product and Services
9.6.4 Bio Farma Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Bio Farma Recent Developments/Updates
9.6.6 Bio Farma Competitive Strengths & Weaknesses
9.7 Panacea Biotec
9.7.1 Panacea Biotec Details
9.7.2 Panacea Biotec Major Business
9.7.3 Panacea Biotec Inactivated Polio Vaccine Product and Services
9.7.4 Panacea Biotec Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Recent Developments/Updates
9.7.6 Panacea Biotec Competitive Strengths & Weaknesses
9.8 Sinovac
9.8.1 Sinovac Details
9.8.2 Sinovac Major Business
9.8.3 Sinovac Inactivated Polio Vaccine Product and Services
9.8.4 Sinovac Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Sinovac Recent Developments/Updates
9.8.6 Sinovac Competitive Strengths & Weaknesses
9.9 Beijing Tiantan Biological
9.9.1 Beijing Tiantan Biological Details
9.9.2 Beijing Tiantan Biological Major Business
9.9.3 Beijing Tiantan Biological Inactivated Polio Vaccine Product and Services
9.9.4 Beijing Tiantan Biological Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Beijing Tiantan Biological Recent Developments/Updates
9.9.6 Beijing Tiantan Biological Competitive Strengths & Weaknesses
9.10 IMBCAMS
9.10.1 IMBCAMS Details
9.10.2 IMBCAMS Major Business
9.10.3 IMBCAMS Inactivated Polio Vaccine Product and Services
9.10.4 IMBCAMS Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 IMBCAMS Recent Developments/Updates
9.10.6 IMBCAMS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Inactivated Polio Vaccine Industry Chain
10.2 Inactivated Polio Vaccine Upstream Analysis
10.2.1 Inactivated Polio Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Inactivated Polio Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Inactivated Polio Vaccine Production Mode
10.6 Inactivated Polio Vaccine Procurement Model
10.7 Inactivated Polio Vaccine Industry Sales Model and Sales Channels
10.7.1 Inactivated Polio Vaccine Sales Model
10.7.2 Inactivated Polio Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Inactivated Polio Vaccine Introduction
1.2 World Inactivated Polio Vaccine Supply & Forecast
1.2.1 World Inactivated Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Inactivated Polio Vaccine Production (2021-2032)
1.2.3 World Inactivated Polio Vaccine Pricing Trends (2021-2032)
1.3 World Inactivated Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Inactivated Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Inactivated Polio Vaccine Production by Region (2021-2032)
1.3.3 World Inactivated Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Inactivated Polio Vaccine Production (2021-2032)
1.3.5 Europe Inactivated Polio Vaccine Production (2021-2032)
1.3.6 China Inactivated Polio Vaccine Production (2021-2032)
1.3.7 Japan Inactivated Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Inactivated Polio Vaccine Demand (2021-2032)
2.2 World Inactivated Polio Vaccine Consumption by Region
2.2.1 World Inactivated Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Inactivated Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Inactivated Polio Vaccine Consumption (2021-2032)
2.4 China Inactivated Polio Vaccine Consumption (2021-2032)
2.5 Europe Inactivated Polio Vaccine Consumption (2021-2032)
2.6 Japan Inactivated Polio Vaccine Consumption (2021-2032)
2.7 South Korea Inactivated Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Inactivated Polio Vaccine Consumption (2021-2032)
2.9 India Inactivated Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Inactivated Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Inactivated Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Inactivated Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Inactivated Polio Vaccine in 2025
3.6 Inactivated Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Inactivated Polio Vaccine Market: Region Footprint
3.6.2 Inactivated Polio Vaccine Market: Company Product Type Footprint
3.6.3 Inactivated Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Inactivated Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Inactivated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Inactivated Polio Vaccine Production Comparison
4.2.1 United States VS China: Inactivated Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Inactivated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Inactivated Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Inactivated Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Inactivated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Inactivated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inactivated Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Inactivated Polio Vaccine Production (2021-2026)
4.5 China Based Inactivated Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inactivated Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Inactivated Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Inactivated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Inactivated Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Childhood Basic Immunization
5.2.2 Special Populations
5.3 Market Segment by Type
5.3.1 World Inactivated Polio Vaccine Production by Type (2021-2032)
5.3.2 World Inactivated Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Inactivated Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VALENCY
6.1 World Inactivated Polio Vaccine Market Size Overview by Valency: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Valency
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.2.4 Multivalent
6.3 Market Segment by Valency
6.3.1 World Inactivated Polio Vaccine Production by Valency (2021-2032)
6.3.2 World Inactivated Polio Vaccine Production Value by Valency (2021-2032)
6.3.3 World Inactivated Polio Vaccine Average Price by Valency (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION CELL
7.1 World Inactivated Polio Vaccine Market Size Overview by Production Cell: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Cell
7.2.1 Vero Cell
7.2.2 Human Diploid
7.2.3 Primary Cell
7.2.4 Recombinant
7.3 Market Segment by Production Cell
7.3.1 World Inactivated Polio Vaccine Production by Production Cell (2021-2032)
7.3.2 World Inactivated Polio Vaccine Production Value by Production Cell (2021-2032)
7.3.3 World Inactivated Polio Vaccine Average Price by Production Cell (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Inactivated Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pediatrics
8.2.2 Adults
8.3 Market Segment by Application
8.3.1 World Inactivated Polio Vaccine Production by Application (2021-2032)
8.3.2 World Inactivated Polio Vaccine Production Value by Application (2021-2032)
8.3.3 World Inactivated Polio Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Inactivated Polio Vaccine Product and Services
9.1.4 Sanofi Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Inactivated Polio Vaccine Product and Services
9.2.4 GSK Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Serum Institute of India
9.3.1 Serum Institute of India Details
9.3.2 Serum Institute of India Major Business
9.3.3 Serum Institute of India Inactivated Polio Vaccine Product and Services
9.3.4 Serum Institute of India Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Serum Institute of India Recent Developments/Updates
9.3.6 Serum Institute of India Competitive Strengths & Weaknesses
9.4 Bharat Biotech
9.4.1 Bharat Biotech Details
9.4.2 Bharat Biotech Major Business
9.4.3 Bharat Biotech Inactivated Polio Vaccine Product and Services
9.4.4 Bharat Biotech Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Bharat Biotech Recent Developments/Updates
9.4.6 Bharat Biotech Competitive Strengths & Weaknesses
9.5 Bilthoven Biologicals
9.5.1 Bilthoven Biologicals Details
9.5.2 Bilthoven Biologicals Major Business
9.5.3 Bilthoven Biologicals Inactivated Polio Vaccine Product and Services
9.5.4 Bilthoven Biologicals Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Bilthoven Biologicals Recent Developments/Updates
9.5.6 Bilthoven Biologicals Competitive Strengths & Weaknesses
9.6 Bio Farma
9.6.1 Bio Farma Details
9.6.2 Bio Farma Major Business
9.6.3 Bio Farma Inactivated Polio Vaccine Product and Services
9.6.4 Bio Farma Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Bio Farma Recent Developments/Updates
9.6.6 Bio Farma Competitive Strengths & Weaknesses
9.7 Panacea Biotec
9.7.1 Panacea Biotec Details
9.7.2 Panacea Biotec Major Business
9.7.3 Panacea Biotec Inactivated Polio Vaccine Product and Services
9.7.4 Panacea Biotec Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Recent Developments/Updates
9.7.6 Panacea Biotec Competitive Strengths & Weaknesses
9.8 Sinovac
9.8.1 Sinovac Details
9.8.2 Sinovac Major Business
9.8.3 Sinovac Inactivated Polio Vaccine Product and Services
9.8.4 Sinovac Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Sinovac Recent Developments/Updates
9.8.6 Sinovac Competitive Strengths & Weaknesses
9.9 Beijing Tiantan Biological
9.9.1 Beijing Tiantan Biological Details
9.9.2 Beijing Tiantan Biological Major Business
9.9.3 Beijing Tiantan Biological Inactivated Polio Vaccine Product and Services
9.9.4 Beijing Tiantan Biological Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Beijing Tiantan Biological Recent Developments/Updates
9.9.6 Beijing Tiantan Biological Competitive Strengths & Weaknesses
9.10 IMBCAMS
9.10.1 IMBCAMS Details
9.10.2 IMBCAMS Major Business
9.10.3 IMBCAMS Inactivated Polio Vaccine Product and Services
9.10.4 IMBCAMS Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 IMBCAMS Recent Developments/Updates
9.10.6 IMBCAMS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Inactivated Polio Vaccine Industry Chain
10.2 Inactivated Polio Vaccine Upstream Analysis
10.2.1 Inactivated Polio Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Inactivated Polio Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Inactivated Polio Vaccine Production Mode
10.6 Inactivated Polio Vaccine Procurement Model
10.7 Inactivated Polio Vaccine Industry Sales Model and Sales Channels
10.7.1 Inactivated Polio Vaccine Sales Model
10.7.2 Inactivated Polio Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Inactivated Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Inactivated Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Inactivated Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Inactivated Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Inactivated Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Inactivated Polio Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Inactivated Polio Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Inactivated Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Inactivated Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Inactivated Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Inactivated Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Inactivated Polio Vaccine Major Market Trends
Table 13. World Inactivated Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Inactivated Polio Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Inactivated Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Inactivated Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Polio Vaccine Producers in 2025
Table 18. World Inactivated Polio Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Inactivated Polio Vaccine Producers in 2025
Table 20. World Inactivated Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Inactivated Polio Vaccine Company Evaluation Quadrant
Table 22. World Inactivated Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Inactivated Polio Vaccine Production Site of Key Manufacturer
Table 24. Inactivated Polio Vaccine Market: Company Product Type Footprint
Table 25. Inactivated Polio Vaccine Market: Company Product Application Footprint
Table 26. Inactivated Polio Vaccine Competitive Factors
Table 27. Inactivated Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Inactivated Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Inactivated Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Inactivated Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Inactivated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Inactivated Polio Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Inactivated Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Inactivated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Inactivated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Inactivated Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Inactivated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Market Share (2021-2026)
Table 47. World Inactivated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Inactivated Polio Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Inactivated Polio Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Inactivated Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Inactivated Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Inactivated Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Inactivated Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Inactivated Polio Vaccine Production Value by Valency, (USD Million), 2021 & 2025 & 2032
Table 55. World Inactivated Polio Vaccine Production by Valency (2021-2026) & (K Dose)
Table 56. World Inactivated Polio Vaccine Production by Valency (2027-2032) & (K Dose)
Table 57. World Inactivated Polio Vaccine Production Value by Valency (2021-2026) & (USD Million)
Table 58. World Inactivated Polio Vaccine Production Value by Valency (2027-2032) & (USD Million)
Table 59. World Inactivated Polio Vaccine Average Price by Valency (2021-2026) & (US$/Dose)
Table 60. World Inactivated Polio Vaccine Average Price by Valency (2027-2032) & (US$/Dose)
Table 61. World Inactivated Polio Vaccine Production Value by Production Cell, (USD Million), 2021 & 2025 & 2032
Table 62. World Inactivated Polio Vaccine Production by Production Cell (2021-2026) & (K Dose)
Table 63. World Inactivated Polio Vaccine Production by Production Cell (2027-2032) & (K Dose)
Table 64. World Inactivated Polio Vaccine Production Value by Production Cell (2021-2026) & (USD Million)
Table 65. World Inactivated Polio Vaccine Production Value by Production Cell (2027-2032) & (USD Million)
Table 66. World Inactivated Polio Vaccine Average Price by Production Cell (2021-2026) & (US$/Dose)
Table 67. World Inactivated Polio Vaccine Average Price by Production Cell (2027-2032) & (US$/Dose)
Table 68. World Inactivated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Inactivated Polio Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Inactivated Polio Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Inactivated Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Inactivated Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Inactivated Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Inactivated Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Inactivated Polio Vaccine Product and Services
Table 78. Sanofi Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Inactivated Polio Vaccine Product and Services
Table 84. GSK Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 88. Serum Institute of India Major Business
Table 89. Serum Institute of India Inactivated Polio Vaccine Product and Services
Table 90. Serum Institute of India Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Serum Institute of India Recent Developments/Updates
Table 92. Serum Institute of India Competitive Strengths & Weaknesses
Table 93. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 94. Bharat Biotech Major Business
Table 95. Bharat Biotech Inactivated Polio Vaccine Product and Services
Table 96. Bharat Biotech Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Bharat Biotech Recent Developments/Updates
Table 98. Bharat Biotech Competitive Strengths & Weaknesses
Table 99. Bilthoven Biologicals Basic Information, Manufacturing Base and Competitors
Table 100. Bilthoven Biologicals Major Business
Table 101. Bilthoven Biologicals Inactivated Polio Vaccine Product and Services
Table 102. Bilthoven Biologicals Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Bilthoven Biologicals Recent Developments/Updates
Table 104. Bilthoven Biologicals Competitive Strengths & Weaknesses
Table 105. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 106. Bio Farma Major Business
Table 107. Bio Farma Inactivated Polio Vaccine Product and Services
Table 108. Bio Farma Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Bio Farma Recent Developments/Updates
Table 110. Bio Farma Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Major Business
Table 113. Panacea Biotec Inactivated Polio Vaccine Product and Services
Table 114. Panacea Biotec Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Recent Developments/Updates
Table 116. Panacea Biotec Competitive Strengths & Weaknesses
Table 117. Sinovac Basic Information, Manufacturing Base and Competitors
Table 118. Sinovac Major Business
Table 119. Sinovac Inactivated Polio Vaccine Product and Services
Table 120. Sinovac Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Sinovac Recent Developments/Updates
Table 122. Sinovac Competitive Strengths & Weaknesses
Table 123. Beijing Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 124. Beijing Tiantan Biological Major Business
Table 125. Beijing Tiantan Biological Inactivated Polio Vaccine Product and Services
Table 126. Beijing Tiantan Biological Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Beijing Tiantan Biological Recent Developments/Updates
Table 128. Beijing Tiantan Biological Competitive Strengths & Weaknesses
Table 129. IMBCAMS Basic Information, Manufacturing Base and Competitors
Table 130. IMBCAMS Major Business
Table 131. IMBCAMS Inactivated Polio Vaccine Product and Services
Table 132. IMBCAMS Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. IMBCAMS Recent Developments/Updates
Table 134. IMBCAMS Competitive Strengths & Weaknesses
Table 135. Global Key Players of Inactivated Polio Vaccine Upstream (Raw Materials)
Table 136. Global Inactivated Polio Vaccine Typical Customers
Table 137. Inactivated Polio Vaccine Typical Distributors
Table 1. World Inactivated Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Inactivated Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Inactivated Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Inactivated Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Inactivated Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Inactivated Polio Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Inactivated Polio Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Inactivated Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Inactivated Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Inactivated Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Inactivated Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Inactivated Polio Vaccine Major Market Trends
Table 13. World Inactivated Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Inactivated Polio Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Inactivated Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Inactivated Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Polio Vaccine Producers in 2025
Table 18. World Inactivated Polio Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Inactivated Polio Vaccine Producers in 2025
Table 20. World Inactivated Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Inactivated Polio Vaccine Company Evaluation Quadrant
Table 22. World Inactivated Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Inactivated Polio Vaccine Production Site of Key Manufacturer
Table 24. Inactivated Polio Vaccine Market: Company Product Type Footprint
Table 25. Inactivated Polio Vaccine Market: Company Product Application Footprint
Table 26. Inactivated Polio Vaccine Competitive Factors
Table 27. Inactivated Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Inactivated Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Inactivated Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Inactivated Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Inactivated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Inactivated Polio Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Inactivated Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Inactivated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Inactivated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Inactivated Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Inactivated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Market Share (2021-2026)
Table 47. World Inactivated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Inactivated Polio Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Inactivated Polio Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Inactivated Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Inactivated Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Inactivated Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Inactivated Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Inactivated Polio Vaccine Production Value by Valency, (USD Million), 2021 & 2025 & 2032
Table 55. World Inactivated Polio Vaccine Production by Valency (2021-2026) & (K Dose)
Table 56. World Inactivated Polio Vaccine Production by Valency (2027-2032) & (K Dose)
Table 57. World Inactivated Polio Vaccine Production Value by Valency (2021-2026) & (USD Million)
Table 58. World Inactivated Polio Vaccine Production Value by Valency (2027-2032) & (USD Million)
Table 59. World Inactivated Polio Vaccine Average Price by Valency (2021-2026) & (US$/Dose)
Table 60. World Inactivated Polio Vaccine Average Price by Valency (2027-2032) & (US$/Dose)
Table 61. World Inactivated Polio Vaccine Production Value by Production Cell, (USD Million), 2021 & 2025 & 2032
Table 62. World Inactivated Polio Vaccine Production by Production Cell (2021-2026) & (K Dose)
Table 63. World Inactivated Polio Vaccine Production by Production Cell (2027-2032) & (K Dose)
Table 64. World Inactivated Polio Vaccine Production Value by Production Cell (2021-2026) & (USD Million)
Table 65. World Inactivated Polio Vaccine Production Value by Production Cell (2027-2032) & (USD Million)
Table 66. World Inactivated Polio Vaccine Average Price by Production Cell (2021-2026) & (US$/Dose)
Table 67. World Inactivated Polio Vaccine Average Price by Production Cell (2027-2032) & (US$/Dose)
Table 68. World Inactivated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Inactivated Polio Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Inactivated Polio Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Inactivated Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Inactivated Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Inactivated Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Inactivated Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Inactivated Polio Vaccine Product and Services
Table 78. Sanofi Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Inactivated Polio Vaccine Product and Services
Table 84. GSK Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 88. Serum Institute of India Major Business
Table 89. Serum Institute of India Inactivated Polio Vaccine Product and Services
Table 90. Serum Institute of India Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Serum Institute of India Recent Developments/Updates
Table 92. Serum Institute of India Competitive Strengths & Weaknesses
Table 93. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 94. Bharat Biotech Major Business
Table 95. Bharat Biotech Inactivated Polio Vaccine Product and Services
Table 96. Bharat Biotech Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Bharat Biotech Recent Developments/Updates
Table 98. Bharat Biotech Competitive Strengths & Weaknesses
Table 99. Bilthoven Biologicals Basic Information, Manufacturing Base and Competitors
Table 100. Bilthoven Biologicals Major Business
Table 101. Bilthoven Biologicals Inactivated Polio Vaccine Product and Services
Table 102. Bilthoven Biologicals Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Bilthoven Biologicals Recent Developments/Updates
Table 104. Bilthoven Biologicals Competitive Strengths & Weaknesses
Table 105. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 106. Bio Farma Major Business
Table 107. Bio Farma Inactivated Polio Vaccine Product and Services
Table 108. Bio Farma Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Bio Farma Recent Developments/Updates
Table 110. Bio Farma Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Major Business
Table 113. Panacea Biotec Inactivated Polio Vaccine Product and Services
Table 114. Panacea Biotec Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Recent Developments/Updates
Table 116. Panacea Biotec Competitive Strengths & Weaknesses
Table 117. Sinovac Basic Information, Manufacturing Base and Competitors
Table 118. Sinovac Major Business
Table 119. Sinovac Inactivated Polio Vaccine Product and Services
Table 120. Sinovac Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Sinovac Recent Developments/Updates
Table 122. Sinovac Competitive Strengths & Weaknesses
Table 123. Beijing Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 124. Beijing Tiantan Biological Major Business
Table 125. Beijing Tiantan Biological Inactivated Polio Vaccine Product and Services
Table 126. Beijing Tiantan Biological Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Beijing Tiantan Biological Recent Developments/Updates
Table 128. Beijing Tiantan Biological Competitive Strengths & Weaknesses
Table 129. IMBCAMS Basic Information, Manufacturing Base and Competitors
Table 130. IMBCAMS Major Business
Table 131. IMBCAMS Inactivated Polio Vaccine Product and Services
Table 132. IMBCAMS Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. IMBCAMS Recent Developments/Updates
Table 134. IMBCAMS Competitive Strengths & Weaknesses
Table 135. Global Key Players of Inactivated Polio Vaccine Upstream (Raw Materials)
Table 136. Global Inactivated Polio Vaccine Typical Customers
Table 137. Inactivated Polio Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Inactivated Polio Vaccine Picture
Figure 2. World Inactivated Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Inactivated Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Inactivated Polio Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Inactivated Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Inactivated Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 12. Inactivated Polio Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World Inactivated Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Inactivated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Polio Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Polio Vaccine Markets in 2025
Figure 26. United States VS China: Inactivated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Inactivated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Inactivated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Inactivated Polio Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Inactivated Polio Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Market Share 2025
Figure 32. World Inactivated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Inactivated Polio Vaccine Production Value Market Share by Type in 2025
Figure 34. Childhood Basic Immunization
Figure 35. Special Populations
Figure 36. World Inactivated Polio Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Inactivated Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Inactivated Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Inactivated Polio Vaccine Production Value by Valency, (USD Million), 2021 & 2025 & 2032
Figure 40. World Inactivated Polio Vaccine Production Value Market Share by Valency in 2025
Figure 41. Monovalent
Figure 42. Bivalent
Figure 43. Trivalent
Figure 44. Multivalent
Figure 45. World Inactivated Polio Vaccine Production Market Share by Valency (2021-2032)
Figure 46. World Inactivated Polio Vaccine Production Value Market Share by Valency (2021-2032)
Figure 47. World Inactivated Polio Vaccine Average Price by Valency (2021-2032) & (US$/Dose)
Figure 48. World Inactivated Polio Vaccine Production Value by Production Cell, (USD Million), 2021 & 2025 & 2032
Figure 49. World Inactivated Polio Vaccine Production Value Market Share by Production Cell in 2025
Figure 50. Vero Cell
Figure 51. Human Diploid
Figure 52. Primary Cell
Figure 53. Recombinant
Figure 54. World Inactivated Polio Vaccine Production Market Share by Production Cell (2021-2032)
Figure 55. World Inactivated Polio Vaccine Production Value Market Share by Production Cell (2021-2032)
Figure 56. World Inactivated Polio Vaccine Average Price by Production Cell (2021-2032) & (US$/Dose)
Figure 57. World Inactivated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Inactivated Polio Vaccine Production Value Market Share by Application in 2025
Figure 59. Pediatrics
Figure 60. Adults
Figure 61. World Inactivated Polio Vaccine Production Market Share by Application (2021-2032)
Figure 62. World Inactivated Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 63. World Inactivated Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 64. Inactivated Polio Vaccine Industry Chain
Figure 65. Inactivated Polio Vaccine Procurement Model
Figure 66. Inactivated Polio Vaccine Sales Model
Figure 67. Inactivated Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Inactivated Polio Vaccine Picture
Figure 2. World Inactivated Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Inactivated Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Inactivated Polio Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Inactivated Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Inactivated Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Inactivated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 12. Inactivated Polio Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World Inactivated Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India Inactivated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Inactivated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Polio Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Polio Vaccine Markets in 2025
Figure 26. United States VS China: Inactivated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Inactivated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Inactivated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Inactivated Polio Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Inactivated Polio Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Market Share 2025
Figure 32. World Inactivated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Inactivated Polio Vaccine Production Value Market Share by Type in 2025
Figure 34. Childhood Basic Immunization
Figure 35. Special Populations
Figure 36. World Inactivated Polio Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Inactivated Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Inactivated Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Inactivated Polio Vaccine Production Value by Valency, (USD Million), 2021 & 2025 & 2032
Figure 40. World Inactivated Polio Vaccine Production Value Market Share by Valency in 2025
Figure 41. Monovalent
Figure 42. Bivalent
Figure 43. Trivalent
Figure 44. Multivalent
Figure 45. World Inactivated Polio Vaccine Production Market Share by Valency (2021-2032)
Figure 46. World Inactivated Polio Vaccine Production Value Market Share by Valency (2021-2032)
Figure 47. World Inactivated Polio Vaccine Average Price by Valency (2021-2032) & (US$/Dose)
Figure 48. World Inactivated Polio Vaccine Production Value by Production Cell, (USD Million), 2021 & 2025 & 2032
Figure 49. World Inactivated Polio Vaccine Production Value Market Share by Production Cell in 2025
Figure 50. Vero Cell
Figure 51. Human Diploid
Figure 52. Primary Cell
Figure 53. Recombinant
Figure 54. World Inactivated Polio Vaccine Production Market Share by Production Cell (2021-2032)
Figure 55. World Inactivated Polio Vaccine Production Value Market Share by Production Cell (2021-2032)
Figure 56. World Inactivated Polio Vaccine Average Price by Production Cell (2021-2032) & (US$/Dose)
Figure 57. World Inactivated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Inactivated Polio Vaccine Production Value Market Share by Application in 2025
Figure 59. Pediatrics
Figure 60. Adults
Figure 61. World Inactivated Polio Vaccine Production Market Share by Application (2021-2032)
Figure 62. World Inactivated Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 63. World Inactivated Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 64. Inactivated Polio Vaccine Industry Chain
Figure 65. Inactivated Polio Vaccine Procurement Model
Figure 66. Inactivated Polio Vaccine Sales Model
Figure 67. Inactivated Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
